A Randomized Trial of Peginterferon alpha-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B


Rijckborst V., ter Borg M. J. , Cakaloglu Y., Ferenci P., Tabak F. , Akdogan M., ...Daha Fazla

AMERICAN JOURNAL OF GASTROENTEROLOGY, cilt.105, ss.1762-1769, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 105 Konu: 8
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1038/ajg.2010.186
  • Dergi Adı: AMERICAN JOURNAL OF GASTROENTEROLOGY
  • Sayfa Sayıları: ss.1762-1769

Özet

OBJECTIVES: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients are at high risk of treatment relapse after any antiviral therapy. Combining peginterferon alpha-2a with ribavirin might improve sustained response rates.